BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 14968296)

  • 1. Incretins, insulin secretion and Type 2 diabetes mellitus.
    Vilsbøll T; Holst JJ
    Diabetologia; 2004 Mar; 47(3):357-366. PubMed ID: 14968296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 and control of insulin secretion.
    Thorens B
    Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes.
    Nauck MA; Baller B; Meier JJ
    Diabetes; 2004 Dec; 53 Suppl 3():S190-6. PubMed ID: 15561910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?
    Holst JJ
    BioDrugs; 2002; 16(3):175-81. PubMed ID: 12102645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of incretin hormones.
    Efendic S; Portwood N
    Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin hormones--an update.
    Holst JJ; Orskov C
    Scand J Clin Lab Invest Suppl; 2001; 234():75-85. PubMed ID: 11713984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
    Creutzfeldt W
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incretin hormones: Their role in health and disease.
    Nauck MA; Meier JJ
    Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapancreatic effects of GIP and GLP-1.
    Vella A; Rizza RA
    Horm Metab Res; 2004; 36(11-12):830-6. PubMed ID: 15655715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus].
    Vilsbøll T; Knop FK
    Ugeskr Laeger; 2007 May; 169(22):2101-5. PubMed ID: 17553392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.
    Holst JJ; Gromada J
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E199-206. PubMed ID: 15271645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility.
    Miki T; Minami K; Shinozaki H; Matsumura K; Saraya A; Ikeda H; Yamada Y; Holst JJ; Seino S
    Diabetes; 2005 Apr; 54(4):1056-63. PubMed ID: 15793244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes.
    Gautier JF; Fetita S; Sobngwi E; Salaün-Martin C
    Diabetes Metab; 2005 Jun; 31(3 Pt 1):233-42. PubMed ID: 16142014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretin hormones and type 2 diabetes.
    Nauck MA; Müller TD
    Diabetologia; 2023 Oct; 66(10):1780-1795. PubMed ID: 37430117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes.
    Gautier JF; Choukem SP; Girard J
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S65-72. PubMed ID: 18640588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incretin notion and its relevance to diabetes.
    Habener JF
    Endocrinol Metab Clin North Am; 1993 Dec; 22(4):775-94. PubMed ID: 8125072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.